Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0I6SI
|
||||
| Former ID |
DNC013154
|
||||
| Drug Name |
3-hydroxy-2-propionylcyclohex-2-enone
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C9H12O3
|
||||
| Canonical SMILES |
CCC(=C1C(=O)CCCC1=O)O
|
||||
| InChI |
1S/C9H12O3/c1-2-6(10)9-7(11)4-3-5-8(9)12/h10H,2-5H2,1H3
|
||||
| InChIKey |
KIXYWPAKWURPPK-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 4-hydroxyphenylpyruvate dioxygenase | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Ubiquinone and other terpenoid-quinone biosynthesis | ||||
| Tyrosine metabolism | |||||
| Phenylalanine metabolism | |||||
| Metabolic pathways | |||||
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2006 Dec 1;16(23):6024-7. Epub 2006 Sep 18.Enzyme inhibition potency enhancement by active site metal chelating and hydrogen bonding induced conformation-restricted cyclopropanecarbonyl derivatives. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.